APO RESEARCH · REPORT
Pharmaceutical Contract Packaging
Pharmaceutical Contract Packaging is the overall process of assembling a Pharmaceutical product into its final finished packaging.
Product & engineering
Understand the product.
Pharmaceutical Contract Packaging is the overall process of assembling a Pharmaceutical product into its final finished packaging.
Selected research
Market Analysis & Forecast
Global Pharmaceutical Contract Packaging Market Analysis and Forecast 2026-2032
Market perspective
Pharmaceutical Contract Packaging is the overall process of assembling a Pharmaceutical product into its final finished packaging.
In North America, Pharmaceutical Contract Packaging key players include Cardinal Health, CCL Industries, PCI Pharma Services, etc. North America top three manufacturers hold a share over 35%.
In terms of product, Plastic Bottles is the largest segment of Cobalt, with a share about 40%. And in terms of application, the largest application is OTC Pharmaceutical Companies, followed by RX Pharmaceutical Companies.
Read the full market overview
Report Includes
This report presents an overview of global market for Pharmaceutical Contract Packaging, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pharmaceutical Contract Packaging, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Contract Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Contract Packaging revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Contract Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Contract Packaging revenue, projected growth trends, production technology, application and end-user industry.
Pharmaceutical Contract Packaging Segment by Company
Cardinal Health
CCL Industries
PCI Pharma Services
Sharp Packaging Services
Berlin Packaging
TricorBraun
Pharma Packaging Solutions
Unicep Packaging
Baxter BioPharma Solutions
Jones Packaging
Ropack Pharma Solutions
Reed-Lane
Precision Medical Products
Pharmaceutical Contract Packaging Segment by Type
Plastic Bottles
Blister Packs
Glass Containers
Others
Pharmaceutical Contract Packaging Segment by Application
OTC Pharmaceutical Companies
RX Pharmaceutical Companies
Others
Pharmaceutical Contract Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pharmaceutical Contract Packaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pharmaceutical Contract Packaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Contract Packaging revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plastic Bottles
- Blister Packs
- Glass Containers
- Others
Applications
- OTC Pharmaceutical Companies
- RX Pharmaceutical Companies
- Others
Companies covered
- Cardinal Health
- CCL Industries
- PCI Pharma Services
- Sharp Packaging Services
- Berlin Packaging
- TricorBraun
- Pharma Packaging Solutions
- Unicep Packaging
- Baxter BioPharma Solutions
- Jones Packaging
- Ropack Pharma Solutions
- Reed-Lane
- Precision Medical Products
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pharmaceutical Contract Packaging Market by Type
- 1.2.1 Global Pharmaceutical Contract Packaging Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Plastic Bottles
- 1.2.3 Blister Packs
- 1.2.4 Glass Containers
- 1.2.5 Others
- 1.3 Pharmaceutical Contract Packaging Market by Application
- 1.3.1 Global Pharmaceutical Contract Packaging Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 OTC Pharmaceutical Companies
- 1.3.3 RX Pharmaceutical Companies
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Contract Packaging Market Dynamics
- 2.1 Pharmaceutical Contract Packaging Industry Trends
- 2.2 Pharmaceutical Contract Packaging Industry Drivers
- 2.3 Pharmaceutical Contract Packaging Industry Opportunities and Challenges
- 2.4 Pharmaceutical Contract Packaging Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pharmaceutical Contract Packaging Market Perspective (2021-2032)
- 3.2 Global Pharmaceutical Contract Packaging Growth Trends by Region
- 3.2.1 Global Pharmaceutical Contract Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pharmaceutical Contract Packaging Market Size by Region (2021-2026)
- 3.2.3 Global Pharmaceutical Contract Packaging Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pharmaceutical Contract Packaging Revenue by Players
- 4.1.1 Global Pharmaceutical Contract Packaging Revenue by Players (2021-2026)
- 4.1.2 Global Pharmaceutical Contract Packaging Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pharmaceutical Contract Packaging Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pharmaceutical Contract Packaging Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pharmaceutical Contract Packaging Key Players Headquarters & Area Served
- 4.4 Global Pharmaceutical Contract Packaging Players, Product Type & Application
- 4.5 Global Pharmaceutical Contract Packaging Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pharmaceutical Contract Packaging Market CR5 and HHI
- 4.6.3 2025 Pharmaceutical Contract Packaging Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Contract Packaging Market Size by Type
- 5.1 Global Pharmaceutical Contract Packaging Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pharmaceutical Contract Packaging Revenue by Type (2021-2032)
- 5.3 Global Pharmaceutical Contract Packaging Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Contract Packaging Market Size by Application
- 6.1 Global Pharmaceutical Contract Packaging Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pharmaceutical Contract Packaging Revenue by Application (2021-2032)
- 6.3 Global Pharmaceutical Contract Packaging Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Cardinal Health
- 7.1.1 Cardinal Health Company Information
- 7.1.2 Cardinal Health Business Overview
- 7.1.3 Cardinal Health Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.1.4 Cardinal Health Pharmaceutical Contract Packaging Product Portfolio
- 7.1.5 Cardinal Health Recent Developments
- 7.2 CCL Industries
- 7.2.1 CCL Industries Company Information
- 7.2.2 CCL Industries Business Overview
- 7.2.3 CCL Industries Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.2.4 CCL Industries Pharmaceutical Contract Packaging Product Portfolio
- 7.2.5 CCL Industries Recent Developments
- 7.3 PCI Pharma Services
- 7.3.1 PCI Pharma Services Company Information
- 7.3.2 PCI Pharma Services Business Overview
- 7.3.3 PCI Pharma Services Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.3.4 PCI Pharma Services Pharmaceutical Contract Packaging Product Portfolio
- 7.3.5 PCI Pharma Services Recent Developments
- 7.4 Sharp Packaging Services
- 7.4.1 Sharp Packaging Services Company Information
- 7.4.2 Sharp Packaging Services Business Overview
- 7.4.3 Sharp Packaging Services Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.4.4 Sharp Packaging Services Pharmaceutical Contract Packaging Product Portfolio
- 7.4.5 Sharp Packaging Services Recent Developments
- 7.5 Berlin Packaging
- 7.5.1 Berlin Packaging Company Information
- 7.5.2 Berlin Packaging Business Overview
- 7.5.3 Berlin Packaging Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.5.4 Berlin Packaging Pharmaceutical Contract Packaging Product Portfolio
- 7.5.5 Berlin Packaging Recent Developments
- 7.6 TricorBraun
- 7.6.1 TricorBraun Company Information
- 7.6.2 TricorBraun Business Overview
- 7.6.3 TricorBraun Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.6.4 TricorBraun Pharmaceutical Contract Packaging Product Portfolio
- 7.6.5 TricorBraun Recent Developments
- 7.7 Pharma Packaging Solutions
- 7.7.1 Pharma Packaging Solutions Company Information
- 7.7.2 Pharma Packaging Solutions Business Overview
- 7.7.3 Pharma Packaging Solutions Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.7.4 Pharma Packaging Solutions Pharmaceutical Contract Packaging Product Portfolio
- 7.7.5 Pharma Packaging Solutions Recent Developments
- 7.8 Unicep Packaging
- 7.8.1 Unicep Packaging Company Information
- 7.8.2 Unicep Packaging Business Overview
- 7.8.3 Unicep Packaging Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.8.4 Unicep Packaging Pharmaceutical Contract Packaging Product Portfolio
- 7.8.5 Unicep Packaging Recent Developments
- 7.9 Baxter BioPharma Solutions
- 7.9.1 Baxter BioPharma Solutions Company Information
- 7.9.2 Baxter BioPharma Solutions Business Overview
- 7.9.3 Baxter BioPharma Solutions Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.9.4 Baxter BioPharma Solutions Pharmaceutical Contract Packaging Product Portfolio
- 7.9.5 Baxter BioPharma Solutions Recent Developments
- 7.10 Jones Packaging
- 7.10.1 Jones Packaging Company Information
- 7.10.2 Jones Packaging Business Overview
- 7.10.3 Jones Packaging Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.10.4 Jones Packaging Pharmaceutical Contract Packaging Product Portfolio
- 7.10.5 Jones Packaging Recent Developments
- 7.11 Ropack Pharma Solutions
- 7.11.1 Ropack Pharma Solutions Company Information
- 7.11.2 Ropack Pharma Solutions Business Overview
- 7.11.3 Ropack Pharma Solutions Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.11.4 Ropack Pharma Solutions Pharmaceutical Contract Packaging Product Portfolio
- 7.11.5 Ropack Pharma Solutions Recent Developments
- 7.12 Reed-Lane
- 7.12.1 Reed-Lane Company Information
- 7.12.2 Reed-Lane Business Overview
- 7.12.3 Reed-Lane Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.12.4 Reed-Lane Pharmaceutical Contract Packaging Product Portfolio
- 7.12.5 Reed-Lane Recent Developments
- 7.13 Precision Medical Products
- 7.13.1 Precision Medical Products Company Information
- 7.13.2 Precision Medical Products Business Overview
- 7.13.3 Precision Medical Products Pharmaceutical Contract Packaging Revenue and Gross Margin (2021-2026)
- 7.13.4 Precision Medical Products Pharmaceutical Contract Packaging Product Portfolio
- 7.13.5 Precision Medical Products Recent Developments
8 North America
- 8.1 North America Pharmaceutical Contract Packaging Revenue (2021-2032)
- 8.2 North America Pharmaceutical Contract Packaging Revenue by Type (2021-2032)
- 8.2.1 North America Pharmaceutical Contract Packaging Revenue by Type (2021-2026)
- 8.2.2 North America Pharmaceutical Contract Packaging Revenue by Type (2027-2032)
- 8.3 North America Pharmaceutical Contract Packaging Revenue Share by Type (2021-2032)
- 8.4 North America Pharmaceutical Contract Packaging Revenue by Application (2021-2032)
- 8.4.1 North America Pharmaceutical Contract Packaging Revenue by Application (2021-2026)
- 8.4.2 North America Pharmaceutical Contract Packaging Revenue by Application (2027-2032)
- 8.5 North America Pharmaceutical Contract Packaging Revenue Share by Application (2021-2032)
- 8.6 North America Pharmaceutical Contract Packaging Revenue by Country
- 8.6.1 North America Pharmaceutical Contract Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pharmaceutical Contract Packaging Revenue by Country (2021-2026)
- 8.6.3 North America Pharmaceutical Contract Packaging Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pharmaceutical Contract Packaging Revenue (2021-2032)
- 9.2 Europe Pharmaceutical Contract Packaging Revenue by Type (2021-2032)
- 9.2.1 Europe Pharmaceutical Contract Packaging Revenue by Type (2021-2026)
- 9.2.2 Europe Pharmaceutical Contract Packaging Revenue by Type (2027-2032)
- 9.3 Europe Pharmaceutical Contract Packaging Revenue Share by Type (2021-2032)
- 9.4 Europe Pharmaceutical Contract Packaging Revenue by Application (2021-2032)
- 9.4.1 Europe Pharmaceutical Contract Packaging Revenue by Application (2021-2026)
- 9.4.2 Europe Pharmaceutical Contract Packaging Revenue by Application (2027-2032)
- 9.5 Europe Pharmaceutical Contract Packaging Revenue Share by Application (2021-2032)
- 9.6 Europe Pharmaceutical Contract Packaging Revenue by Country
- 9.6.1 Europe Pharmaceutical Contract Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pharmaceutical Contract Packaging Revenue by Country (2021-2026)
- 9.6.3 Europe Pharmaceutical Contract Packaging Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pharmaceutical Contract Packaging Revenue (2021-2032)
- 10.2 China Pharmaceutical Contract Packaging Revenue by Type (2021-2032)
- 10.2.1 China Pharmaceutical Contract Packaging Revenue by Type (2021-2026)
- 10.2.2 China Pharmaceutical Contract Packaging Revenue by Type (2027-2032)
- 10.3 China Pharmaceutical Contract Packaging Revenue Share by Type (2021-2032)
- 10.4 China Pharmaceutical Contract Packaging Revenue by Application (2021-2032)
- 10.4.1 China Pharmaceutical Contract Packaging Revenue by Application (2021-2026)
- 10.4.2 China Pharmaceutical Contract Packaging Revenue by Application (2027-2032)
- 10.5 China Pharmaceutical Contract Packaging Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pharmaceutical Contract Packaging Revenue (2021-2032)
- 11.2 Asia Pharmaceutical Contract Packaging Revenue by Type (2021-2032)
- 11.2.1 Asia Pharmaceutical Contract Packaging Revenue by Type (2021-2026)
- 11.2.2 Asia Pharmaceutical Contract Packaging Revenue by Type (2027-2032)
- 11.3 Asia Pharmaceutical Contract Packaging Revenue Share by Type (2021-2032)
- 11.4 Asia Pharmaceutical Contract Packaging Revenue by Application (2021-2032)
- 11.4.1 Asia Pharmaceutical Contract Packaging Revenue by Application (2021-2026)
- 11.4.2 Asia Pharmaceutical Contract Packaging Revenue by Application (2027-2032)
- 11.5 Asia Pharmaceutical Contract Packaging Revenue Share by Application (2021-2032)
- 11.6 Asia Pharmaceutical Contract Packaging Revenue by Country
- 11.6.1 Asia Pharmaceutical Contract Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pharmaceutical Contract Packaging Revenue by Country (2021-2026)
- 11.6.3 Asia Pharmaceutical Contract Packaging Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pharmaceutical Contract Packaging Revenue (2021-2032)
- 12.2 SAMEA Pharmaceutical Contract Packaging Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pharmaceutical Contract Packaging Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pharmaceutical Contract Packaging Revenue by Type (2027-2032)
- 12.3 SAMEA Pharmaceutical Contract Packaging Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pharmaceutical Contract Packaging Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pharmaceutical Contract Packaging Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pharmaceutical Contract Packaging Revenue by Application (2027-2032)
- 12.5 SAMEA Pharmaceutical Contract Packaging Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pharmaceutical Contract Packaging Revenue by Country
- 12.6.1 SAMEA Pharmaceutical Contract Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pharmaceutical Contract Packaging Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pharmaceutical Contract Packaging Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst